First new migraine drug for 20 years is set to be rejected for use on the NHS

The treatment, developed by NHS-funded UK scientists over the last three decades, has been available privately since September at the cost of £386 a month.

Source: the Mail online | Health - January 10, 2019 Category: Consumer Health News Source Type: news